SIRT2 inhibition as the Achilles’ heel of ATRX-deficient gliomas
ATRX is a chromatin remodeling protein that facilitates H3.3 deposition at telomeres and pericentromeric heterochromatin. It is essential for normal brain development, and mutations in ATRX cause alpha thalassemia X-linked intellectual disability (ATR-X) syndrome, a disorder characterized by severe...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
January 2024
|
| In: |
Neuro-Oncology
Year: 2024, Jahrgang: 26, Heft: 1, Pages: 68-69 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/noad217 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/noad217
|
| Verfasserangaben: | Şevin Turcan |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 187796302X | ||
| 003 | DE-627 | ||
| 005 | 20240307021050.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240112s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/neuonc/noad217 |2 doi | |
| 035 | |a (DE-627)187796302X | ||
| 035 | |a (DE-599)KXP187796302X | ||
| 035 | |a (OCoLC)1425200006 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Turcan, S̨evin |e VerfasserIn |0 (DE-588)1167189582 |0 (DE-627)103087414X |0 (DE-576)511022093 |4 aut | |
| 245 | 1 | 0 | |a SIRT2 inhibition as the Achilles’ heel of ATRX-deficient gliomas |c Şevin Turcan |
| 264 | 1 | |c January 2024 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Veröffentlicht: 06 November 2023 | ||
| 500 | |a Gesehen am 12.01.2024 | ||
| 520 | |a ATRX is a chromatin remodeling protein that facilitates H3.3 deposition at telomeres and pericentromeric heterochromatin. It is essential for normal brain development, and mutations in ATRX cause alpha thalassemia X-linked intellectual disability (ATR-X) syndrome, a disorder characterized by severe cognitive defects.1 In pediatric high-grade gliomas, recurrent loss-of-function mutations in ATRX are frequently reported with TP53 and H3F3A mutations.2 In adult gliomas, ATRX is mutated in astrocytomas, co-occurring with IDH1 and TP53 mutations, and in high-grade astrocytomas with piloid features, a recently described molecular class of IDH-wildtype glioma.3 Furthermore, ATRX-deficient tumors exhibit a distinct molecular landscape where telomere length is maintained in a telomerase-independent manner, known as alternative lengthening of telomeres (ALT).4 | ||
| 773 | 0 | 8 | |i Enthalten in |t Neuro-Oncology |d Oxford : Oxford Univ. Press, 1999 |g 26(2024), 1, Seite 68-69 |h Online-Ressource |w (DE-627)357167341 |w (DE-600)2094060-9 |w (DE-576)318041839 |x 1523-5866 |7 nnas |a SIRT2 inhibition as the Achilles’ heel of ATRX-deficient gliomas |
| 773 | 1 | 8 | |g volume:26 |g year:2024 |g number:1 |g pages:68-69 |g extent:2 |a SIRT2 inhibition as the Achilles’ heel of ATRX-deficient gliomas |
| 856 | 4 | 0 | |u https://doi.org/10.1093/neuonc/noad217 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240112 | ||
| 993 | |a Editorial | ||
| 994 | |a 2024 | ||
| 998 | |g 1167189582 |a Turcan, S̨evin |m 1167189582:Turcan, S̨evin |d 910000 |d 911100 |e 910000PT1167189582 |e 911100PT1167189582 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN187796302X |e 4455957367 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"S̨evin","display":"Turcan, S̨evin","family":"Turcan","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title_sort":"SIRT2 inhibition as the Achilles’ heel of ATRX-deficient gliomas","title":"SIRT2 inhibition as the Achilles’ heel of ATRX-deficient gliomas"}],"name":{"displayForm":["Şevin Turcan"]},"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 21.07.23"],"part":{"issue":"1","volume":"26","pages":"68-69","extent":"2","text":"26(2024), 1, Seite 68-69","year":"2024"},"origin":[{"publisher":"Oxford Univ. Press ; Duke University Medical Center","dateIssuedKey":"1999","dateIssuedDisp":"1999-","publisherPlace":"Oxford ; Durham, NC"}],"pubHistory":["1.1999 -"],"recId":"357167341","id":{"issn":["1523-5866"],"eki":["357167341"],"zdb":["2094060-9"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Neuro-Oncology","subtitle":"official journal of the World Federation of Neuro-Oncology","title_sort":"Neuro-Oncology"}],"disp":"SIRT2 inhibition as the Achilles’ heel of ATRX-deficient gliomasNeuro-Oncology"}],"note":["Veröffentlicht: 06 November 2023","Gesehen am 12.01.2024"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"January 2024"}],"recId":"187796302X","id":{"doi":["10.1093/neuonc/noad217"],"eki":["187796302X"]},"physDesc":[{"extent":"2 S."}],"language":["eng"]} | ||
| SRT | |a TURCANSEVISIRT2INHIB2024 | ||